Rizikos analizė dar nepasiekiama šios šalies konkursams. Šiuo metu palaikomos: Estija, Lenkija, Lietuva ir Latvija.
Gaukite dirbtinio intelekto parengtą laimėjimo strategiją, pritaikytą šiam konkursui. Apima laimėjimo tikimybės balą, pagrindines galimybes ir iššūkius, rekomenduojamas pasiūlymo sritis, konkurencinės padėties analizę ir praktinius patarimus jūsų galimybėms maksimizuoti.
PrisijungtiAtnaujinkite, kad matytumėte, kurios įmonės greičiausiai pateiks pasiūlymą šiam konkursui, remiantis istoriniais viešųjų pirkimų duomenimis.
Prisijungti9 reikalavimų 5 kategorijose
Prisiregistruokite, kad peržiūrėtumėte visus reikalavimus ir analizę
Yra 4 dokumentų su AI santraukomis
This notice invites suppliers to participate in voluntary preliminary market engagement for a potential £3 billion, 8-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.
This document is an OCDS release package detailing a preliminary market engagement by NHS Supply Chain for a potential £3 billion framework agreement over eight years for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies.
This notice invites suppliers to participate in preliminary market engagement for a potential £3 billion, eight-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.
Prisiregistruokite, kad peržiūrėtumėte dokumentų santraukas ir analizę
This is a well-structured preliminary market engagement notice for a significant framework agreement. While it lacks formal tender elements like evaluation criteria and e-submission, this is appropriate for its 'planning' status and PME nature.
The notice clearly defines itself as a preliminary market engagement (PME) and references the UK Procurement Act 2023, indicating compliance with national regulations for this stage. The CPV code is appropriate, and there are no disputes or suspensions.
The description is very clear and unambiguous, explaining the purpose, scope, and potential duration/value of the future framework agreement. The requirements, as extracted, are clear within the context of a PME.
Basic information (title, reference, organization, value, duration) is present. Requirements for PME participation are defined. However, one document failed to download, which is a minor completeness issue.
The PME is explicitly open and voluntary, indicating a fair approach to market engagement. Requirements are generic and not tailored. The absence of e-submission is a minor drawback for equal access.
The lack of e-submission functionality is a significant practical drawback for participation. Other practical details like contract start date and duration are clearly specified.
Data is largely consistent and logical, with dates aligning appropriately. The estimated values in GBP and EUR are roughly consistent. The 'Liable Person' field is empty, which is a minor inconsistency.
The notice explicitly mentions 'encouraging openness to innovation' and 'advanced diabetes technologies,' which is a positive. However, there are no explicit green procurement or social criteria mentioned.
Prisiregistruokite, kad peržiūrėtumėte visus reikalavimus ir analizę
Nereikia kreditinės kortelės • Sąranka per 2 minutes
Mūsų viešųjų pirkimų ekspertai parengia viską. Įrodytas sprendimas — jūs peržiūrit, patvirtinate ir pateikiate.
Sveiki! Aš esu jūsų AI asistentas, skirtas šiam konkursui. Galiu padėti jums suprasti reikalavimus, terminus, tinkamumo kriterijus ir pateikti strateginių įžvalgų.
Nereikia kreditinės kortelės